Order Article Reprints

Lazzaro A, Bianchini D, Gentilini Cacciola E, Mezzaroma I, Falciano M, Andreoni C, Fimiani C, Santinelli L, Maddaloni L, Bugani G, et al. Immune Reconstitution and Safe Metabolic Profile after the Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate among Virologically Controlled PLWH: A 96 Week Update from the BICTEL Cohort. Viruses. 2023; 15(6):1222. https://doi.org/10.3390/v15061222

Lazzaro, Alessandro, Diana Bianchini, Elio Gentilini Cacciola, Ivano Mezzaroma, Mario Falciano, Carolina Andreoni, Caterina Fimiani, Letizia Santinelli, Luca Maddaloni, Ginevra Bugani, and et al. 2023. "Immune Reconstitution and Safe Metabolic Profile after the Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate among Virologically Controlled PLWH: A 96 Week Update from the BICTEL Cohort" Viruses 15, no. 6: 1222. https://doi.org/10.3390/v15061222

Lazzaro, A., Bianchini, D., Gentilini Cacciola, E., Mezzaroma, I., Falciano, M., Andreoni, C., Fimiani, C., Santinelli, L., Maddaloni, L., Bugani, G., Ceccarelli, G., Mastroianni, C. M., & d’Ettorre, G. (2023). Immune Reconstitution and Safe Metabolic Profile after the Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate among Virologically Controlled PLWH: A 96 Week Update from the BICTEL Cohort. Viruses, 15(6), 1222. https://doi.org/10.3390/v15061222